Who is the manufacturer of Illumeo System?

Philips Medical Systems Technologies , Ltd. filed the 510(k) submission for Illumeo System (K173588).

What is the FDA product code for Illumeo System?

LLZ. It is classified under 21 CFR 892.2050 as a Class 2 device in the Radiology panel.

What is the regulatory pathway for Illumeo System?

510(k) clearance (submission type: Special).

What are the predicate devices for Illumeo System?

I4 (Integrated Intelligent Imaging Informatics) (K160315).

Who can help prepare an FDA 510(k) submission like Illumeo System?

Innolitics — a medical-device software consultancy — provides regulatory and engineering support for FDA 510(k) submissions. See https://innolitics.com/services/510ks/ or contact https://innolitics.com/contact.

Illumeo System

K173588 · Philips Medical Systems Technologies , Ltd. · LLZ · Jan 12, 2018 · Radiology

Device Facts

Record ID	K173588
Device Name	Illumeo System
Applicant	Philips Medical Systems Technologies , Ltd.
Product Code	LLZ · Radiology
Decision Date	Jan 12, 2018
Decision	SESE
Submission Type	Special
Regulation	21 CFR 892.2050
Device Class	Class 2
Attributes	Software as a Medical Device

Intended Use

Illumeo system is an image management system intended to be used by trained professionals, including but not limited to radiologists. Illumeo system is a software package used with general purpose computing hardware to acquire, store, distribute, process and display images and associated data throughout a clinical environment. The software performs digital image processing, measurement, manipulation and quantification of images, communication and storage. This device is not to be used for mammography.

Device Story

Illumeo is a software-based image management system (PACS) for clinical environments; operated by radiologists and trained professionals. It ingests medical images (CT, MR, US, XA, DX, CR, RF, PET, SPECT, SC) and non-imaging data via DICOM and hospital/radiology information systems. The system performs digital image processing, 2D/3D visualization, measurement, and quantification. Key features include patient briefing (integrating lab results/documents), vascular inspection/quantification, and hanging protocols for study display. It supports client-server architecture and an HTML5-based enterprise viewer for clinical review. Output is displayed on high-resolution diagnostic monitors to assist clinicians in image interpretation and evaluation. By centralizing imaging and patient context, the device facilitates diagnostic workflows and longitudinal tracking of findings, potentially improving clinical decision-making and patient care efficiency.

Clinical Evidence

No clinical studies were required or performed. Substantial equivalence is supported by non-clinical verification and validation testing, including software life cycle processes (IEC 62304), risk management (ISO 14971), usability engineering (IEC 62366-1), and DICOM conformance (NEMA-PS 3.1-3.20).

Technological Characteristics

Software-based PACS running on general-purpose Windows hardware. Utilizes client-server architecture with thin-client and HTML5-based enterprise viewer. Supports DICOM connectivity for multiple modalities (CT, MR, US, XA, DX, CR, RF, PET, SPECT, SC). Features include 2D/3D image processing, measurement tools, and EMR/RIS integration via FHIR. Complies with ISO 14971, IEC 62304, IEC 62366-1, and NEMA DICOM standards.

Indications for Use

Indicated for trained professionals, including radiologists, for the acquisition, storage, distribution, processing, and display of medical images and associated data in a clinical environment. Not for use in mammography.

Regulatory Classification

Identification

A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.

Special Controls

*Classification.* Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).

Predicate Devices

I4 (Integrated Intelligent Imaging Informatics) (K160315)

Reference Devices

Intellispace Portal Platform (K162025)
Multi-Modality Tumor Tracking (MMTT) Application (K162955)

Related Devices

K160315 — I4 (Integrated Intelligent Imaging Informatics) system · Philips Medical Systems Nederland B.V. · Feb 19, 2016
K182926 — IntelliSpace Radiology · Philips Healthcare Informatics, Inc. · Dec 6, 2018
K190232 — Synapse PACS · Fujifilm Corporation · Mar 26, 2019
K063267 — ISITE PACS, V 4. X · Stentor Inc., A Philips Medical Systems Co. · Nov 9, 2006
K111945 — IMPAX NEXT GENERATION · Agfa Healthcare N.V. · Aug 5, 2011

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/0 description: The image contains two logos. The logo on the left is the Department of Health & Human Services - USA logo. The logo on the right is the FDA U.S. Food & Drug Administration logo. The FDA logo is blue and white. Philips Medical Systems Technologies Ltd. % Mr. Yoram Levy QA/RA Consultant Qsite 31 Haavoda Street Binyamina 30500 ISRAEL January 12, 2018 Re: K173588 Trade/Device Name: Illumeo System Regulation Number: 21 CFR 892.2050 Regulation Name: Picture archiving and communications system Regulatory Class: II Product Code: LLZ, JAK Dated: January 2, 2018 Received: January 8, 2018 Dear Mr. Levy: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); {1}------------------------------------------------ and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100). Sincerely, Michael D.'Hara For Robert Ochs. Ph.D. Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ # Indications for Use 510(k) Number (if known) K173588 Device Name Illumeo system Indications for Use (Describe) Illumeo system is an image management system intended to be used by trained professionals, including but not limited to radiologists. Illumeo system is a software package used with general purpose computing hardware to acquire, store, distribute, process and display images and associated data throughout a clinical environment. The software performs digital image processing, measurement, manipulation and quantification of images, communication and storage. This device is not to be used for mammography. Type of Use (Select one or both, as applicable) | <input checked="true" type="checkbox"/> Prescription Use (Part 21 CFR 801 Subpart D) | |--------------------------------------------------------------------------------------------------------------------------------------| | <input type="checkbox"/> Over-The-Counter Use (21 CFR 801 Subpart C) | ### CONTINUE ON A SEPARATE PAGE IF NEEDED. This section applies only to requirements of the Paperwork Reduction Act of 1995. ### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.* The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: > Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." {3}------------------------------------------------ Image /page/3/Picture/1 description: The image shows the word "PHILIPS" in large, bold, blue letters. The font is sans-serif and the letters are evenly spaced. The word is the only element in the image and it is centered. # 510(K) SUMMARY This 510(k) summary of safety and effectiveness information is prepared in accordance with 21 CFR 807.92. | Date Prepared: | November 16, 2017 | |-----------------|------------------------------------------------| | Submission Type | Special 510(k): Device Modification submission | ### I. Submitter's name and address - Manufacturer: Philips Medical Systems Nederland B.V. Veenpluis 4-6 5684 PC Best The Netherlands Establishment Registration Number: 3003768277 ### Primary Contact Persons: Yoram Levy, Qsite 31 Haavoda Street, Binyamina 30500 Israel Phone: (972)4-638-8837 Fax: (972)4-638-0510 E-mail: Yoram@qsitemed.com ### Secondary Contact: Ilana Ben Moshe Quality & Regulatory Affairs Leader Medical Systems Nederland B.V Phone: +972 525233496 E-mail: Ilana.Ben-Moshe@philips.com # II. Device information ### Subject Device: | Device Name: | Illumeo system | |--------------------|----------------------------| | Common/Usual Name: | Imaging Informatics System | Classification: | Classification name: | Picture Archiving and Communications System | |----------------------------|---------------------------------------------| | Device class: | Class II | | Classification regulation: | 21 CFR 892.2050 | | Classification panel: | Radiology | 2-2 # Illumeo System Special 510k Submission {4}------------------------------------------------ Image /page/4/Picture/1 description: The image shows the word "PHILIPS" in large, bold, blue letters. The font is sans-serif and the letters are evenly spaced. The word is centered and takes up most of the frame. The background is plain white. Primary Product Code: LLZ Secondary Product Code: JAK Comment: Product commercial name was changed from I4 (Integrated Intelligent Imaging Informatics) System to Illumeo system for marketing reasons. #### Predicate device information III. # Primary Predicate Device: | Trade name: | I4 (Integrated Intelligent Imaging Informatics) | |----------------------------|-------------------------------------------------| | Manufacturer: | Philips Healthcare Informatics, Inc. | | 510(k) clearance: | K160315 | | Classification name: | Picture Archiving and Communications System | | Device class: | Class II | | Classification regulation: | 21 CFR 892.2050 | | Classification panel: | Radiology | | Product code: | LLZ, JAK | # Reference Predicate Device: | Trade name: | Intellispace Portal Platform | |----------------------------|--------------------------------------------------| | Manufacturer: | Philips Medical Systems Nederland B.V. | | 510(k) clearance: | K162025 | | Classification name: | Picture Archiving and Communications System | | Device class: | Class II | | Classification regulation: | 21 CFR 892.2050 | | Classification panel: | Radiology | | Product code: | LLZ | | Trade name: | Multi-Modality Tumor Tracking (MMTT) Application | | Manufacturer: | Philips Medical Systems Nederland B.V. | | 510(k) clearance: | K162955 | | Classification name: | Picture Archiving and Communications System | | Device class: | Class II | | Classification regulation: | 21 CFR 892.2050 | | Classification panel: | Radiology | | Product code: | LLZ | {5}------------------------------------------------ ### IV. Device Description Illumeo is an image management system intended to be used by trained professionals, including but not limited to radiologists. Illumeo system is a software package used with general purpose computing hardware to acquire, store, distribute, process and display images and associated data throughout a clinical environment. The software performs digital image processing, measurement, manipulation and quantification of images, communication and storage. This device is not to be used for mammography. Illumeo is a medical software system offering a primary interpretation solution for visualization and evaluation a variety of medical images deriving from various imaging modalities as well as non-imaging information. Illumeo interconnects with clinical imaging and non-imaging data sources to present in addition to images non-imaging data in patient context. Comment: Product commercial name was changed from I4 (Integrated Intelligent Imaging Informatics) System to Illumeo for marketing reasons. # Device modifications The proposed Illumeo system includes the following minor modifications, compared to the primary predicate device, I4 (Integrated Intelligent Imaging Informatics) system (K160315). Description of the device modifications: - 1. Improved performance of the software image management system -communication to PACS using dedicated interfaces and automatic preprocessing on data arrival for enhanced performance. - 2. Integration with IntelliSpace PACS improvements in data retrieval through FHIR interface and reporting workflow, interface with Electronic Medical Record (EMR) and Radiology Information System (RIS) - 3. Scalability - Illumeo v2.0 supports up to 50 concurrent users using hosted client and up to 150 concurrent users using enterprise viewer. - 4. Multimodality and Multivendor support: Additional Multimodality supported - SPECT, improved Multivendor support, support for Presentation states (PR), PET/CT fusion of a single study - 5. Patient briefing including additional information such as prior findings, recent Lab Results, Scanned documents, Patient Location and type. - 6. 2D and 3D viewing enhanced additional tools - 7. Findings creation and management improvements including Match finding feature enabling track and measure change over time. # Illumeo System Special 510k Submission {6}------------------------------------------------ Image /page/6/Picture/1 description: The image shows the word "PHILIPS" in large, bold, blue letters. The letters are evenly spaced and appear to be a sans-serif font. The background is white, providing a strong contrast that makes the word stand out. - 8. Comparison and Synchronization enhanced capabilities such as compare mode between current and prior studies, comparison inspector presenting the same region of interest in the same study or compared to prior studies, manual link/unlink datasets. - Hanging protocols (HP) functionality which enables to present presets that define how 9. a study is displayed (layout), which series will be displayed by default and what viewing parameters are used. Hanging Protocols are multi - modality as per study type. - 10. Vascular Inspection mode/ Vascular Quantification inspector enhanced vascular inspection mode including local vascular inspection mode - 11. User Interface Improvements - 12. Enterprise Viewer Illumeo system includes Enterprise viewer a fully HTML5 based viewer version, embedding Findings Presenter functionalities to address Enterprise clinical review by the specialists. Enterprise viewer zero footprint viewer requires no installation, and runs on most common operating systems and browsers. Enterprise Viewer is not intended to be used on mobile platforms. The proposed Illumeo system includes modifications which are considered minor technology changes mainly designated to provide users further support in visualization. The presented device modifications do not affect/change neither Intended Use nor alter the fundamental scientific technology of the device. Therefore Philips believes a Special 510(k) is the appropriate type of submission # V. Indications for Use Illumeo system is an image management system intended to be used by trained professionals, including but not limited to radiologists. Illumeo system is a software package used with general purpose computing hardware to acquire, store, distribute, process and display images and associated data throughout a clinical environment. The software performs digital image processing, measurement, manipulation and quantification of images, communication and storage. This device is not to be used for mammography. # Indications for Use Discussion The proposed device, Illumeo system, is a software package used with general purpose computing hardware to acquire, store, distribute, process and display images and associated data throughout a clinical environment, identical to the primary predicate device. I4 (Integrated Intelligent Imaging Informatics) system (K160315). {7}------------------------------------------------ Image /page/7/Picture/1 description: The image shows the word "PHILIPS" in large, bold, blue letters. The font is sans-serif and the letters are evenly spaced. The word is centered and takes up most of the frame. The background is white. Illumeo system software is designed to perform digital image processing, measurement, manipulation and quantification of images, communication and storage with indications for use identical to the primary predicate device, I4 (Integrated Intelligent Imaging Informatics) system (K160315). The Indications for Use statement for I4 (Integrated Intelligent Imaging Informatics) is identical compared to the primary predicate device. I4 (Integrated Intelligent Imaging Informatics) system (K160315). Based on the above, the proposed Illumeo system is considered substantially equivalent to the currently marketed and primary predicate device I4 (Integrated Intelligent Imaging Informatics) system (K160315), in terms of Indications for use. #### VI. Comparison of Technological Characteristics with the Predicate Device The proposed Illumeo system is an evolution of previously cleared I4 (Integrated Intelligent Imaging Informatics) system (K160315), with additional minor modifications deriving from the identified predicate and reference devices. Illumeo v2.0 is an evolution of llumeo v1.0 system, formerly also known as I4 (Integrated Intelligent Imaging Informatics) System. The product commercial name was changed from I4 (Integrated Intelligent Imaging Informatics) System to Illumeo system, for marketing reasons. Illumeo system is a software package used with general purpose computing hardware. Illumeo system uses the standard principles of operation typically seen in PACS systems such as database and image management systems, image processing tools, and standard measurement tools. Both the proposed device and the primary predicate device, I4 (Integrated Intelligent Imaging Informatics) system (K160315), provide Diagnostic Review Solution for radiology, utilizing client -server technology, storage capabilities, communication and interoperability with hospital systems. Both the proposed device and the primary predicate device. I4 (Integrated Intelligent Imaging Informatics) system (K160315), offer a primary interpretation solution for visualization and evaluation variety of medical images deriving from various imaging modalities as well as nonimaging information. Illumeo and its primary predicate device interconnect with clinical imaging and non-imaging data sources to present in addition to images non-imaging data in patient context. The proposed device, Illumeo system, has implemented features designated to bring the product up to date with current technologies and customer requests. {8}------------------------------------------------ Image /page/8/Picture/0 description: The image shows the word "PHILIPS" in large, bold, blue letters. The font is sans-serif and the letters are evenly spaced. The word is centered and takes up most of the frame. The background is white. A comparison table below (please see Table No.2- 1 below) provides a comparison which outlines a high-level overview of the differences and similarities between Illumeo system and the primary predicate device, I4 (Integrated Intelligent Imaging Informatics) system (K160315). | # | Specification / Feature | Illumeo System (Proposed device) | I4 (Integrated Intelligent Imaging Informatics) System (K160315) (Primary Predicate Device) | |------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | 1. | Software Image management system | Yes | Yes | | 2. | Hardware Platform requirements | Yes | Yes | | System Configuration | | | | | 3. | Windows Operating System | Yes | Yes | | 4. | TCP-IP Network Protocol | Yes | Yes | | 5. | Supports High Resolution Diagnostic Monitors | Yes | Yes | | 6. | Storage capabilities | Yes | Yes | | 7. | Multiple monitor support | Yes | Yes | | Communication and Interoperability with other image management systems | | | | | 8. | Supports DICOM studies received from different modalities types | Yes CT, MR, US, XA, DX, CR, RF, PET, SC, SPECT, as well as hospital/radiology information system | Yes | | 9. | Mammography | No | No | | 10. | Accepts patient and exam updates | Yes | Yes | | Operating Platform requirements | | | | | 11. | Client-server technology | Yes | Yes | | # | Specification / Feature | Illumeo System (Proposed device) | I4 (Integrated Intelligent Imaging Informatics) System (K160315) (Primary Predicate Device) | | 12. | Thin client installer | Yes | Yes | | 13. | Multiple concurrent user support | Yes Up to 50 concurrent users using hosted clientUp to 150 concurrent users using Enterprise Viewer | Yes Up to 10 concurrent users | | Management tools | | | | | 14. | Auditing Tool | Yes | Yes | | 15. | Client installer | Yes | Yes | | 16. | System management | Yes | Yes | | 17. | Security and Privacy | Yes | Yes | | Viewing and Image Processing | | | | | 18. | Supported Data and Multi Modalities | Supports receiving, sending, storing and displaying studies received from the following modalities via DICOM: CT, MR, US, XA, DX, CR, RF, PET, SPECT and SC as well as hospital /radiology information systems. | Supports receiving, sending, storing and displaying studies received from the following modalities via DICOM: CT, MR, US, XA, DX, CR, RF, PET and SC as well as hospital /radiology information systems. | | 19. | 2D viewing capabilities | Yes | Yes | | # | Specification / Feature | Illumeo System (Proposed device) | 14 (Integrated Intelligent Imaging Informatics) System (K160315) (Primary Predicate Device) | | 20. | 3D viewing capabilities | Yes | Yes | | 21. | Finding creation and management tool | Yes | Yes | | 22. | Comparison and Synchronization between volumetric series | Yes | Yes | | 23. | Hanging protocols (HP) | Yes | Yes | | 24. | Advanced vessel analysis visualization and evaluation mode - Vascular Quantification Inspector (Vascular Inspection Mode) | Yes | Yes | | 25. | Incorporation of non-imaging data in patient context (Patient Briefing) | Yes | Yes | | 26. | Enterprise Diagnostic web viewer | Yes | Yes | | 27. | Non - Diagnostic Enterprise web viewer | Yes | Yes | # Table No.2- 1 Technological characteristics comparison {9}------------------------------------------------ Image /page/9/Picture/1 description: The image shows the word "PHILIPS" in large, bold, blue letters. The font is sans-serif and the letters are evenly spaced. The word is centered and takes up most of the frame. The background is white. {10}------------------------------------------------ Image /page/10/Picture/1 description: The image shows the word "PHILIPS" in a bold, sans-serif font. The word is written in blue color. The background is white. {11}------------------------------------------------ Image /page/11/Picture/1 description: The image shows the word "PHILIPS" in large, bold, blue letters. The letters are evenly spaced and aligned horizontally. The background is plain white, which makes the blue letters stand out. The proposed device. Illumeo system, has implemented features designated to bring the product up to date with current technologies and customer requests. Presented technological differences are considered low risk, providing further support to users/clinicians in visualization. All the above listed device modifications were verified and validated demonstrating that the design outputs of the modified device meet the design input requirements and do not raise new questions on safety and/or effectiveness. These features have not changed the intended use and the fundamental scientific technology of the device. Therefore, the proposed Illumeo system is substantially equivalent to the currently marketed primary predicate device I4 (Integrated Intelligent Imaging Informatics) System (K160315) in terms of technological characteristics. Conclusion The proposed Illumeo system is Substantially Equivalent to the currently marketed primary predicate device, I4 (Integrated Intelligent Imaging Informatics) System (K160315), in terms of Indication for Use, design features, fundamental scientific technology, and safety and/or effectiveness #### VII. Performance Data Section 16 'Software' provides a summary of the technical documentation which includes nonclinical verification and validation tests. These tests are performed with regards to the intended use, the technical claims, the requirement specifications and the risk management results, and according to the following International and FDA-recognized consensus standards and FDA guidance document. The following performance data were provided in support of the substantial equivalence determination. # Summary of Non-clinical testing No performance standards for PACS systems or components have been issued under the authority of Section 514. Non-clinical performance testing has been performed on Illumeo system and demonstrates compliance with the following International and FDA-recognized consensus standards and FDA guidance document: - I ISO 14971 Medical devices - Application of risk management to medical devices - IEC 62304 Medical device software Software life cycle processes l # Illumeo System Special 510k Submission {12}------------------------------------------------ Image /page/12/Picture/1 description: The image shows the word "PHILIPS" in large, bold, blue letters. The font is sans-serif and the letters are evenly spaced. The word is centered and takes up most of the frame. - I IEC 62366-1 Medical devices – Part 1:Application of usability engineering to medical devices - l NEMA-PS 3.1- PS 3.20 Digital Imaging and Communications in Medicine (DICOM) - . Guidance for Industry and FDA Staff - Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices Illumeo system was tested in accordance with Philips verification and validation processes. Verification and Validation tests have been performed to address intended use, the technological characteristics claims, requirement specifications and the risk management results. The test results in this Special 510(k): Device Modification submission demonstrates that Illumeo system: - . Complies with the aforementioned international and FDA-recognized consensus standards and FDA guidance document, and - Meets the acceptance criteria and is adequate for its intended use and user needs. Additionally, the risk management activities show that all risks are sufficiently mitigated, that no new risks are introduced, and that the overall residual risks are acceptable. Therefore, Illumeo system is substantially equivalent to the currently marketed primary predicate device I4 (Integrated Intelligent Imaging Informatics) System (K160315) in terms of safety and effectiveness. # Summary of Clinical Testing The subject of this Special 510(k): Device Modification submission, Illumeo system did not requires clinical studies to support equivalence. #### Substantial Equivalence Conclusion VIII. The Illumeo system is substantially equivalent to the currently marketed primary predicate device (Integrated Intelligent Imaging Informatics) System (K160315) in terms of Indications for Use, design features, fundamental scientific technology, and safety and/or effectiveness. Additionally, substantial equivalence was demonstrated with non-clinical performance testing. Verification and Validation (V&V) activities were performed for proposed Illumeo system and demonstrated that the predetermined acceptance criteria were successfully met. The non-clinical performance tests provided in this Special 510(k): Device Modification submission demonstrated that the proposed Illumeo system is as safe and effective as its primary predicate device I4 (Integrated Intelligent Imaging Informatics) System (K160315) without raising any new safety and/or effectiveness concerns.